It has been demonstrated that suppressing TXNIP/NLRP3 inflammasome can markedly repress inflammation in cigarette smoke-stimulated COPD model (Mahalanobish et al., 2020; Tian et al., 2021). Here, TXNIP is linked to chronic obstructive pulmonary disease.